Investigative protocols for chronotherapeutics. Basic requirements and illustrative case histories.
Smolensky
M H
MH
Department of Environmental Sciences, School of Public Health, University of Texas Health Science Center, Houston 77030.
D'Alonzo
G E
GE
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D002940:Circadian Rhythm; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006635:Histamine H2 Antagonists / Q000008:administration & dosage; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D013806:Theophylline / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006635:Histamine H2 Antagonists; D004364:Pharmaceutical Preparations; D004317:Doxorubicin; D013806:Theophylline; D002945:Cisplatin